TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF THE NORTH AMERICA SMART CONTACT LENS MARKET 21
1.4 LIMITATIONS 23
1.5 MARKETS COVERED 23
2 MARKET SEGMENTATION 25
2.1 MARKETS COVERED 25
2.2 GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 26
2.4 CURRENCY AND PRICING 26
2.5 DBMR TRIPOD DATA VALIDATION MODEL 27
2.6 MULTIVARIATE MODELLING 30
2.7 DESIGN LIFELINE CURVE 30
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.9 DBMR MARKET POSITION GRID 32
2.10 MARKET APPLICATION COVERAGE GRID 33
2.11 SECONDARY SOURCES 34
2.12 ASSUMPTIONS 34
3 EXECUTIVE SUMMARY 35
4 PREMIUM INSIGHTS 38
4.1 PORTERS FIVE FORCES 39
4.2 PESTEL ANALYSIS 40
4.3 LIST OF TERMINATED/PAUSED PIPELINE PROJECTS 41
4.4 PATENT ANALYSIS 42
4.5 PIPELINE ANALYSIS FOR THE NORTH AMERICA SMART CONTACT LENS MARKET 44
4.6 INDUSTRY INSIGHT 45
5 NORTH AMERICA SMART CONTACT LENS MARKET: REGULATIONS 46
6 MARKET OVERVIEW 49
6.1 DRIVERS 51
6.1.1 INCREASE IN PREVALENCE OF REFRACTIVE ERROR 51
6.1.2 RISING CASES OF DIABETIC RETINOPATHY 52
6.1.3 INCREASING R&D ACTIVITIES BY KEY MARKET PLAYERS FOR SMART CONTACT LENS 52
6.1.4 RISE IN THE PREVALENCE OF EYE DISORDER 53
6.2 RESTRAINTS 53
6.2.1 INCREASING SIDE EFFECTS ASSOCIATED WITH CONTACT LENSES 53
6.2.2 GROWING ACCEPTANCE OF REFRACTIVE SURGERIES 54
6.3 OPPORTUNITIES 54
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN CONTACT LENSES 54
6.3.2 INCREASING PREFERENCE FOR CONTACT LENSES INSTEAD OF EYEGLASSES 55
6.4 CHALLENGES 55
6.4.1 SAFETY CONCERNS ASSOCIATED WITH THE USE OF CONTACT LENSES 55
6.4.2 STRICT REGULATIONS AND STANDARDS FOR APPROVAL OF CONTACT LENSES 56
7 NORTH AMERICA SMART CONTACT LENS MARKET, BY DESIGN 57
7.1 OVERVIEW 58
7.2 MICRO LED DISPLAY CONTACT LENS 61
7.3 DIAGNOSTIC SENSOR INTEGRATED CONTACT LENS 61
7.4 PHOTODETECTOR CONTACT LENSES 62
7.5 DRUG ELUDING CONTACT LENSES 62
7.6 ELECTROCHEMICAL CONTACT LENS SENSORS 63
7.7 LIGHT DIFFRACTIVE CONTACT LENSES 63
7.8 FLUORESCENCE-BASED CONTACT LENSES 64
7.9 OTHERS 64
8 NORTH AMERICA SMART CONTACT LENS MARKET, BY MATERIAL 65
8.1 OVERVIEW 66
8.2 POLY (2-HYDROXYETHYL METHACRYLATE) (PHEMA) 69
8.3 POLYVINYL ALCOHOL (PVA) 69
8.4 POLYACRYLAMIDE (PA) 70
8.5 POLYETHYLENE TEREPHTHALATE (PET) 70
8.6 POLYDIMETHYLSILOXANE (PDMS) 71
8.7 OTHER 72
9 NORTH AMERICA SMART CONTACT LENS MARKET, BY APPLICATION 73
9.1 OVERVIEW 74
9.2 MONITORING 77
9.2.1 EYE PRESSURE MONITORING 77
9.2.2 GLUCOSE LEVELS MONITORING 77
9.3 THERAPEUTICS 78
9.3.1 ALLERGY RELIEF 78
9.3.2 CORNEAL INJURY 79
9.3.3 EYE INJURIES 79
9.3.4 OTHER 79
9.4 OTHER APPLICATION 79
9.4.1 FARSIGHTEDNESS 80
9.4.2 AUGMENTED REALITY (AR/VR) 80
9.4.3 NIGHT VISION 80
9.4.4 OTHERS 80
10 NORTH AMERICA SMART CONTACT LENS MARKET, BY USABILITY 81
10.1 OVERVIEW 82
10.2 SINGLE USE 85
10.3 EXTENDED USE 86
11 NORTH AMERICA SMART CONTACT LENS MARKET, BY TECHNOLOGY 87
11.1 OVERVIEW 88
11.2 FLUORESCENCE-BASED SENSING TECHNOLOGY 91
11.3 HOLOGRAPHIC SENSING TECHNOLOGY 92
11.4 COLORIMETRIC BASED SENSING TECHNOLOGY 93
11.5 ELECTROCHEMICAL-BASED TECHNOLOGIES 94
11.6 OTHER 95
12 NORTH AMERICA SMART CONTACT LENS MARKET, BY POPULATION 96
12.1 OVERVIEW 97
12.2 GERIATRIC 100
12.3 ADULT 101
12.4 PEDIATRIC 102
13 NORTH AMERICA SMART CONTACT LENS MARKET, BY END USER 103
13.1 OVERVIEW 104
13.2 EYE HOSPITAL 107
13.3 OPHTHALMOLOGY CLINICS 108
13.4 HOMECARE SETTING 109
13.5 OTHERS 110
14 NORTH AMERICA SMART CONTACT LENS MARKET, BY DISTRIBUTION CHANNEL 111
14.1 OVERVIEW 112
14.2 RETAIL STORES 115
14.2.1 PHARMACIES 115
14.2.2 INDEPENDENT BRAND SHOWROOMS 116
14.2.3 OTHERS 116
14.3 ONLINE STORES 116
14.3.1 E-COMMERCE WEBSITES 117
14.3.2 COMPANY-OWNED WEBSITES 117
14.4 EYE CARE PRACTITIONERS 117
14.5 OTHERS 118
15 NORTH AMERICA SMART CONTACT LENS MARKET, BY REGION 119
15.1 NORTH AMERICA 120
15.1.1 U.S 129
16 SWOT ANALYSIS 133
17 COMPANY PROFILE 134
17.1 SENSIMED AG 134
17.1.1 COMPANY SNAPSHOT 134
17.1.2 PRODUCT PORTFOLIO 134
17.1.3 RECENT DEVELOPMENT 134
17.2 AZALEA VISION 135
17.2.1 COMPANY SNAPSHOT 135
17.2.2 PRODUCT PORTFOLIO 135
17.2.3 RECENT DEVELOPMENTS 135
17.3 E-VISION SMART OPTICS, INC. 136
17.3.1 COMPANY SNAPSHOT 136
17.3.2 PRODUCT PORTFOLIO 136
17.3.3 RECENT DEVELOPMENT 136
17.4 GLAKOLENS BIYOMEDIKAL BIYOTEKNOLOJI SAN. VE TIC. A.. 137
17.4.1 COMPANY SNAPSHOT 137
17.4.2 PIPELINE PORTFOLIO 137
17.4.3 RECENT DEVELOPMENTS 137
17.5 INNOVEGA INC. 138
17.5.1 COMPANY SNAPSHOT 138
17.5.2 PIPELINE PORTFOLIO 138
17.5.3 RECENT DEVELOPMENTS 138
17.6 INWITH CORP 139
17.6.1 COMPANY SNAPSHOT 139
17.6.2 PIPELINE PORTFOLIO 139
17.6.3 RECENT DEVELOPMENT 139
17.7 MEDIPRINT 140
17.7.1 COMPANY SNAPSHOT 140
17.7.2 PRODUCT PORTFOLIO 140
17.7.3 RECENT DEVELOPMENTS 140
17.8 RAAYONNOVA 141
17.8.1 COMPANY SNAPSHOT 141
17.8.2 PRODUCT PORTFOLIO 141
17.8.3 RECENT DEVELOPMENTS 141
17.9 SAMSUNG 142
17.9.1 COMPANY SNAPSHOT 142
17.9.2 REVENUE ANALYSIS 142
17.9.3 PRODUCT PORTFOLIO 143
17.9.4 RECENT DEVELOPMENT 143
18 QUESTIONNAIRE 144
19 RELATED REPORTS 148

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.